approval
saveHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalOct 16, 2025 · 353d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 29, 2025 · 432d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMay 20, 2025 · 502d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJun 12, 2024 · 844d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 5, 2024 · 912d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 14, 2023 · 1269d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMar 20, 2023 · 1294d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022 · 1539d ago
same company · ±60 days · 6
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalAug 24, 2023
- approvaldexmethylphenidate hydrochloride ER: FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 13, 2023
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 13, 2023
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 13, 2023
- approvalAZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 13, 2023
- approvalAZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalOct 13, 2023
comments(0)
5-min edit window · permanent after that